INVEGA SUSTENNA PACKAGE INSERT PDF

adminComment(0)

INVEGA SUSTENNA® is an atypical antipsychotic indicated for. • Treatment of monthly maintenance dose, refer to the Full Prescribing Information. (). See full prescribing information for complete boxed warning. Conversion from the INVEGA SUSTENNA® 39 mg dose was not studied. • Missed Doses. HIGHLIGHTS OF PRESCRIBING INFORMATION. These highlights do not include all the information needed to use. INVEGA SUSTENNA® safely and effectively.


Invega Sustenna Package Insert Pdf

Author:TAMMERA KROUSE
Language:English, Arabic, Dutch
Country:Belize
Genre:Health & Fitness
Pages:232
Published (Last):11.05.2016
ISBN:545-2-49082-909-9
ePub File Size:30.58 MB
PDF File Size:15.34 MB
Distribution:Free* [*Registration Required]
Downloads:42870
Uploaded by: CARMINE

See full Prescribing Information for complete Boxed Warning. • Elderly DAY Recommended dosing for INVEGA SUSTENNA® (paliperidone palmitate). Discontinuation of the previous antipsychotic should be made in accordance with the appropriate prescribing information. If INVEGA SUSTENNA is discontinued. This leaflet answers some of the common questions about Invega. Sustenna. It does Invega Sustenna belongs to a group Do not use it if the packaging is.

Call your healthcare professional right away if you have any of these symptoms: passing out or feeling like you will pass out; dizziness; or feeling as if your heart is pounding or missing beats uncontrolled movements of your tongue, face, mouth, or jaw tardive dyskinesia metabolic changes.

Metabolic changes may include high blood sugar hyperglycemia , diabetes mellitus and changes in the fat levels in your blood dyslipidemia , and weight gain low blood pressure and fainting changes in your blood cell counts high level of prolactin in your blood hyperprolactinemia.

Call your healthcare professional or go to your nearest emergency room right away if you have an erection that lasts more than 4 hours problems with control of your body temperature, especially when you exercise a lot or spend time doing things that make you warm.

Tell your healthcare professional if you have any side effect that bothers you or does not go away. For more information, ask your healthcare professional or pharmacist.

You might also like: FOOD PACKAGING EBOOK

Call your doctor for medical advice about side effects. You are encouraged to report side effects of prescription drugs to the FDA.

Visit www. Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. It may harm them.

If you would like more information, talk with your healthcare professional.

INVEGA SUSTENNA®_ Home

You can ask your healthcare professional or pharmacist for more information that is written for healthcare professionals. For more information, go to www. Prescribing should be consistent with the need to minimize the risk of TD see full Prescribing Information.

Discontinue drug if clinically appropriate. The syndrome may remit, partially or completely, if antipsychotic treatment is withdrawn. These metabolic changes include hyperglycemia, dyslipidemia, and body weight gain.

Educational Dose Illustrator

While all of the drugs in the class have been shown to produce some metabolic changes, each drug has its own specific risk profile. Hyperglycemia and Diabetes Mellitus: Hyperglycemia and diabetes mellitus, in some cases extreme and associated with ketoacidosis, hyperosmolar coma or death, have been reported in patients treated with all atypical antipsychotics APS.

Patients starting treatment with APS who have or are at risk for diabetes mellitus should undergo fasting blood glucose testing at the beginning of and during treatment. Patients who develop symptoms of hyperglycemia during treatment should also undergo fasting blood glucose testing. All patients treated with atypical antipsychotics should be monitored for symptoms of hyperglycemia.

Paliperidone palmitate: Once-monthly treatment option for schizophrenia

Some patients require continuation of antidiabetic treatment despite discontinuation of the suspect drug. Dyslipidemia: Undesirable alterations have been observed in patients treated with atypical antipsychotics. Weight Gain: Weight gain has been observed with atypical antipsychotic use.

Clinical monitoring of weight is recommended. Monitoring should be considered in patients for whom this may be of concern. For patients, particularly the elderly, with diseases, conditions, or medications that could exacerbate these effects, assess the risk of falls when initiating antipsychotic treatment and recurrently for patients on long-term antipsychotic therapy.

Monitor patients with clinically significant neutropenia for fever or other symptoms or signs of infection and treat promptly if such symptoms or signs occur. Paliperidone has a prolactin-elevating effect similar to risperidone, which is associated with higher levels of prolactin elevation than other antipsychotic agents. Conditions that lower seizure threshold may be more prevalent in patients 65 years or older.

Care should be taken to avoid inadvertent injection into a blood vessel. If administering a strong inducer is necessary, consider managing the patient using paliperidone extended-release tablets. These medications are not approved for the treatment of patients with dementia-related psychosis. Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death.

The incidence of CAEs was significantly higher than with placebo. Elderly women appear to be at increased risk for TD, although it is impossible to predict which patients will develop the syndrome. Patients who develop symptoms of hyperglycemia should also undergo fasting blood glucose testing. Monitor glucose regularly in patients with diabetes or at risk for diabetes.

Hyperprolactinemia: As with other drugs that antagonize dopamine D2 receptors, risperidone elevates prolactin levels and the elevation persists during chronic administration. Risperidone is associated with higher levels of prolactin elevation than other antipsychotic agents. Dysphagia: Esophageal dysmotility and aspiration have been associated with antipsychotic drug use.

References

Aspiration pneumonia is a common cause of morbidity and mortality in patients with advanced Alzheimer's dementia. Use cautiously in patients at risk for aspiration pneumonia. Priapism has been reported.Your doctor may order an EKG to monitor for irregular heart beat.

Third party trademarks used herein are trademarks of their respective owners. Keep a list of them to show to your healthcare professional or pharmacist when you get a new medicine.

This palmitate ester of paliperidone is an aqueous suspension utilizing nanocrystal molecules. Some people may develop muscle related side effects while taking paliperidone.